Cassava Sciences, Inc. (SAVA)
3.15
-0.11
(-3.37%)
USD |
NASDAQ |
Dec 11, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Cash from Financing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Biogen, Inc. | -130.20M |
| Geron Corp. | 0.542M |
| Ovid Therapeutics, Inc. | 0.015M |
| NovaBay Pharmaceuticals, Inc. | -1.319M |
| Palatin Technologies, Inc. | 0.3282M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.221M |
| Cash from Investing (Quarterly) | -0.08M |
| Free Cash Flow | -83.91M |
| Free Cash Flow Per Share (Quarterly) | -0.1304 |
| Free Cash Flow to Equity (Quarterly) | -6.301M |
| Free Cash Flow to Firm (Quarterly) | -6.301M |
| Free Cash Flow Yield | -55.21% |